The public’s perception of the industry is low. How can we fix it?

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

Experts discuss the trends, challenges, and possibilities of cryopreservation for cell and gene – and how it can freeze time in manufacturing.

Research and development in sleep-wake disorders has been asleep on its feet

Looking for words of wisdom and tips on being a leader and advancing your career in pharma?

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.